RHD and alloimmunization: To date, the published SR evidence supporting established protocols for prevention of Rh alloimmunization have been limited by methodological flaws (e.g., suboptimal risk of bias assessment), have been restricted to randomized controlled trials (RCTs), and have not all evaluated the certainty of the evidence [6–8].